Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Analysis and ERG in Acute VKH
NCT03811366Completed
- Sponsor
- Universidade de São Paulo
- Start
- Jun 2011
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of prednisone and methylprednisolone in Vogt-Koyanagi-Harada disease (VKH), sponsored by Universidade de São Paulo. Primary endpoints: Median Values of ERG Scotopic Parameters at 24 months and Variation Between 24 and 12 Months of ERG Scotopic Parameters at 24 months. Started Jun 2011; status: completed.
02
Drugs
prednisonemethylprednisolone
03
Conditions
Vogt-Koyanagi-Harada disease (VKH)
Beyond the preview
Go deeper on NCT03811366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03811366.